Cargando…
Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress
Alexander disease is a fatal neurological disorder caused by mutations in the intermediate filament protein Glial Fibrillary Acidic Protein (GFAP), which is key for astrocyte homeostasis. These mutations cause GFAP aggregation, astrocyte dysfunction and neurodegeneration. Remarkably, most of the kno...
Autores principales: | Viedma-Poyatos, Álvaro, González-Jiménez, Patricia, Pajares, María A., Pérez-Sala, Dolores |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364016/ https://www.ncbi.nlm.nih.gov/pubmed/35933901 http://dx.doi.org/10.1016/j.redox.2022.102415 |
Ejemplares similares
-
Protein Lipoxidation: Basic Concepts and Emerging Roles
por: Viedma-Poyatos, Álvaro, et al.
Publicado: (2021) -
Vimentin disruption by lipoxidation and electrophiles: Role of the cysteine residue and filament dynamics
por: Mónico, Andreia, et al.
Publicado: (2019) -
Lipoxidation targets: From basic mechanisms to pathophysiology
por: Pérez-Sala, Dolores, et al.
Publicado: (2019) -
Type III intermediate filaments as targets and effectors of electrophiles and oxidants
por: Viedma-Poyatos, Álvaro, et al.
Publicado: (2020) -
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease
por: Bachetti, Tiziana, et al.
Publicado: (2021)